Key Takeaways
- Stress can lead to bloating by increasing inflammation and causing gut bacteria imbalances.
- Irritable bowel syndrome (IBS) symptoms, including bloating and abdominal distention, are strongly associated with stress levels.
- Non-gut-related issues, like pelvic floor dysfunction, can cause chronic bloating.
- Bloating and other gastrointestinal (GI) symptoms can be easily treated with lifestyle and dietary changes, probiotics, and physical therapy.
The link between stress and increased IBS symptoms like bloating is well-established. This is likely due to stress changing the gut microbiota, leading to dysbiosis and/or bacterial overgrowth. These gut flora changes can lead to excess gas production and inflammation inside the GI tract. Unfortunately, as inflammation levels increase, our pain sensitivity also increases, adding to the sensation of bloating.
Can Stress Cause Bloating?
Stress can disrupt the normal gut microbiome, creating intestinal dysbiosis and bacterial overgrowth. These changes can lead to digestive symptoms, including bloating. This may be due in part to excess gas production that may cause the sensation of bloating and physical distention, though the exact mechanism hasn’t been confirmed by research.What Is Bloating?
Bloating is the subjective feeling of pressure or gas in the abdomen. It’s important to note that this is different from distention, which refers to the physical expansion of the abdomen [1]. However, these symptoms often present together, and over half of the people who experience bloating also report abdominal distention [1].- Irritable bowel syndrome (IBS) [1]
- Inflammatory bowel disease (IBD) [3]
- Small intestine bacterial overgrowth (SIBO) [1, 2, 4, 5]
- Chronic constipation [1]
- Dyspepsia and indigestion [1]
- Exocrine pancreatic insufficiency (EPI) [1, 2, 6, 7]
- Gastroparesis [1, 2]
- Gallbladder dysfunction [8]
- Stomach ulcers [9]
- Chronic overeating [5]
Stress and Irritable Bowel Syndrome (IBS)
IBS is a common gut disorder and is a frequent cause of bloating and abdominal distention. One study found that all patients with diagnosed IBS, regardless of the subtype, experience more sensations of bloating than healthy controls. Furthermore, nearly half of IBS patients experienced physical abdominal distention [10].- Gas, bloating, and abdominal distention
- Constipation
- Diarrhea
- Stomach pain
- Cramping
Regardless of the exact mechanism, there appears to be a strong correlation between IBS symptoms and stress.

Bloating in Other GI Conditions
Because of the communication between the digestive system and the brain, stress likely increases symptoms of bloating and abdominal distention in other functional GI disorders.Other Possible Causes of Bloating
Many other chronic health conditions can often present with abdominal bloating and distention. This includes disorders and other underlying factors like:- Certain medications
- Hypothyroidism [1, 2]
- Obesity [1]
- Type-2 diabetes [2]
- Autoimmunity [2, 19, 20]
- Menstruation and ovarian cysts [21, 22, 23]
Abdominal Muscle Dysfunction
Abnormal contractions in the diaphragm and belly muscles after eating can cause the nervous system to create a heightened sense of bloating. This abnormal “viscerosomatic reflex” causes poor posture and distention of the abdominal muscles, and may worsen bloating sensations [24].Pelvic Floor Dysfunction
Stressful situations naturally cause our muscles to tighten and can lead to increased contractions in the muscles of the pelvic floor. These muscles control our bladder, bowel, and sexual function. When they are overly contracted (too tight) they can create a condition known as high-tone pelvic floor dysfunction [25].This positive response further strengthens the evidence that our brains and digestive tracts are connected. Overall, stress appears to increase the likelihood of bloating by affecting multiple body systems, including the digestive, nervous, and musculoskeletal systems.

Your 5-Step Guide to Reducing Stress-Induced Bloating
While much of the following research on relieving stress and GI symptoms was performed on those with IBS, we’ve found the below therapies to be helpful for people with other conditions that result in bloating and abdominal distention.Step 1: Lifestyle Changes
Stress management: Stress-reduction techniques can reduce the “fight or flight response” that happens during times of stress and can improve your gut health. Cognitive behavioral therapy (CBT), biofeedback, and meditation all help reduce stress levels and relieve stress-induced bloating [27, 28, 29].- Fast walking
- Biking on a flat surface
- Water aerobics
- Basketball, tennis, volleyball, and other sports
Step 2: Change Your Diet
Start by following an elimination diet to help heal your gut, reduce inflammation, and determine which foods might be triggering your symptoms.- Sugar
- Processed foods
- Gluten-containing foods and other grains
- Dairy
It is important to note that everyone’s food triggers may be different and it may take some experimentation to figure out what may be causing your bloating and other GI symptoms.
Step 3: Introduce Probiotics
Probiotics are highly effective at reducing symptoms of GI disorders, including bloating and abdominal distention [45, 46, 47, 48]. Probiotics help to dampen the dysbiosis that occurs from stress and can help restore the normal gut flora.
Step 4: Targeted Supplement and Dietary Treatments
If your bloating and/or stomach distention isn’t solved by dietary and lifestyle changes alone, it may be time for a more targeted approach.- Supplements: Research suggests that digestive enzymes can help reduce symptoms of bloating, abdominal pain, and flatulence [53, 54]. One enzyme in particular, ɑ-galactosidase, may be beneficial in alleviating colic in children and is considered to be safe [55].
- Intermittent Fasting: One study showed that intermittent fasting successfully reduced bloating, abdominal pain, diarrhea, nausea, and anxiety in those with IBS [56]. Intermittent fasting focuses on abstaining from eating for a certain period each day. Many people start with a 16-hour fasting window, but there are many variations, and you should always do what’s best for you.
- Elemental Diet: Don’t worry if fasting isn’t appropriate for you, as an elemental diet can effectively resolve stubborn IBS-related symptoms, like gas and bloating, in just two to three weeks [57]. The elemental diet is formulated to be easily digested, it reduces inflammation in the GI tract, and helps increase nutrient absorption. The elemental diet is easy to incorporate and can be used alone, or alongside another diet.
- Medications: Rifaxamin is a popular antibiotic that’s used to treat dysbiosis and infections in the GI tract. It’s considered safe by health care practitioners, as it’s not absorbed into the bloodstream, lessening its side effects. Rifaxamin is highly effective at reducing IBS symptoms, particularly bloating, and it may take as little as two weeks to see significant results [58]. Furthermore, rifaxamin may offer long-term relief from bloating, even after finishing the course of antibiotics [59].
Step 5: Physical Therapy
Those with bloating related to pelvic floor dysfunction may benefit from seeing a physical therapist who specializes in pelvic floor therapy. Manual physical therapy can effectively break up adhesions (scar tissue) that constrict organs and lead to abdominal distension and bloating sensations [60].
Summary: Can Stress Cause Bloating?
Research supports that stress is a likely cause of bloating in both GI disorders and non-gut-related conditions. The gut-brain axis provides a powerful pathway of communication between the brain and digestive tract, allowing stress to increase inflammation and dysbiosis in the gut.Fortunately, there are some basic steps that you can take to improve your symptoms of bloating and abdominal distention.
◇ References:
- Lacy BE, Cangemi D, Vazquez-Roque M. Management of chronic abdominal distension and bloating. Clin Gastroenterol Hepatol. 2021 Feb;19(2):219-231.e1. DOI: 10.1016/j.cgh.2020.03.056. PMID: 32246999.
- Mari A, Abu Backer F, Mahamid M, Amara H, Carter D, Boltin D, et al. Bloating and abdominal distension: clinical approach and management. Adv Ther. 2019 May;36(5):1075–84. DOI: 10.1007/s12325-019-00924-7. PMID: 30879252. PMCID: PMC6824367.
- Nemeth V, Pfleghaar N. Diarrhea. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 28846339.
- Ghoshal UC. Antibiotic treatment for small intestinal bacterial overgrowth: Is a cocktail better than a single? United European Gastroenterol J. 2021 Jul;9(6):643–4. DOI: 10.1002/ueg2.12075. PMID: 33951351. PMCID: PMC8280792.
- Zhang L, Sizar O, Higginbotham K. Meteorism. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 28613601.
- Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 2010 May;8(5):433–8. DOI: 10.1016/j.cgh.2009.09.032. PMID: 19835990.
- Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018 Feb 5;72(2). DOI: 10.1111/ijcp.13066. PMID: 29405509. PMCID: PMC5873407.
- Jones MW, Genova R, O’Rourke MC. Acute Cholecystitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 29083809.
- Malik TF, Gnanapandithan K, Singh K. Peptic Ulcer Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 30521213.
- Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology. 2006 Oct;131(4):1003–10. DOI: 10.1053/j.gastro.2006.07.015. PMID: 17030170.
- Roohafza H, Bidaki EZ, Hasanzadeh-Keshteli A, Daghaghzade H, Afshar H, Adibi P. Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study. Adv Biomed Res. 2016 Nov 28;5:183. DOI: 10.4103/2277-9175.190938. PMID: 28028523. PMCID: PMC5156966.
- Chen H-H, Hung C-H, Kao A-W, Hsieh H-F. Exploring Quality of Life, Stress, and Risk Factors Associated with Irritable Bowel Syndrome for Female University Students in Taiwan. Int J Environ Res Public Health. 2021 Apr 7;18(8). DOI: 10.3390/ijerph18083888. PMID: 33917268. PMCID: PMC8068066.
- Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. 2017 Dec;7:124–36. DOI: 10.1016/j.ynstr.2017.03.001. PMID: 29276734. PMCID: PMC5736941.
- Major G, Pritchard S, Murray K, Alappadan JP, Hoad CL, Marciani L, et al. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology. 2017 Jan;152(1):124-133.e2. DOI: 10.1053/j.gastro.2016.09.062. PMID: 27746233.
- Amieva-Balmori M, Coss-Adame E, Rao NS, Dávalos-Pantoja BM, Rao SSC. Diagnostic utility of carbohydrate breath tests for SIBO, fructose, and lactose intolerance. Dig Dis Sci. 2020 May;65(5):1405–13. DOI: 10.1007/s10620-019-05889-9. PMID: 31617133.
- Schnedl WJ, Lackner S, Enko D, Schenk M, Holasek SJ, Mangge H. Evaluation of symptoms and symptom combinations in histamine intolerance. Intest Res. 2019 Jul;17(3):427–33. DOI: 10.5217/ir.2018.00152. PMID: 30836736. PMCID: PMC6667364.
- Dieterich W, Zopf Y. Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary? Nutrients. 2019 Aug 20;11(8). DOI: 10.3390/nu11081957. PMID: 31434299. PMCID: PMC6723650.
- Croall ID, Hoggard N, Aziz I, Hadjivassiliou M, Sanders DS. Brain fog and non-coeliac gluten sensitivity: Proof of concept brain MRI pilot study. PLoS ONE. 2020 Aug 28;15(8):e0238283. DOI: 10.1371/journal.pone.0238283. PMID: 32857796. PMCID: PMC7454984.
- Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Rev Gastroenterol Hepatol. 2020 Feb;14(2):93–102. DOI: 10.1080/17474124.2020.1718491. PMID: 31951768.
- Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B. Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study. Medicine (Baltimore). 2017 Jan;96(1):e5784. DOI: 10.1097/MD.0000000000005784. PMID: 28072728. PMCID: PMC5228688.
- Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol. 2014 Jun 14;20(22):6725–43. DOI: 10.3748/wjg.v20.i22.6725. PMID: 24944465. PMCID: PMC4051914.
- Southwell BR. Treatment of childhood constipation: a synthesis of systematic reviews and meta-analyses. Expert Rev Gastroenterol Hepatol. 2020 Mar;14(3):163–74. DOI: 10.1080/17474124.2020.1733974. PMID: 32098515.
- Ovarian cysts: Overview – InformedHealth.org – NCBI Bookshelf [Internet]. 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539572/
- Livovsky DM, Barber C, Barba E, Accarino A, Azpiroz F. Abdominothoracic postural tone influences the sensations induced by meal ingestion. Nutrients. 2021 Feb 18;13(2). DOI: 10.3390/nu13020658. PMID: 33670508. PMCID: PMC7922384.
- Grimes WR, Stratton M. Pelvic Floor Dysfunction. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32644672.
- Iovino P, Neri MC, D’Alba L, Santonicola A, Chiarioni G. Pelvic floor biofeedback is an effective treatment for severe bloating in disorders of gut-brain interaction with outlet dysfunction. Neurogastroenterol Motil. 2021 Sep 16;e14264. DOI: 10.1111/nmo.14264. PMID: 34532928.
- Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 Jan;114(1):21–39. DOI: 10.1038/s41395-018-0222-5. PMID: 30177784.
- Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020 Aug;69(8):1441–51. DOI: 10.1136/gutjnl-2020-321191. PMID: 32276950.
- Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology. 2018 Jul;155(1):47–57. DOI: 10.1053/j.gastro.2018.03.063. PMID: 29702118. PMCID: PMC6035059.
- Thakur ER, Shapiro J, Chan J, Lumley MA, Cully JA, Bradford A, et al. A systematic review of the effectiveness of psychological treatments for IBS in gastroenterology settings: promising but in need of further study. Dig Dis Sci. 2018 Sep;63(9):2189–201. DOI: 10.1007/s10620-018-5095-3. PMID: 29744772.
- Zernicke KA, Campbell TS, Blustein PK, Fung TS, Johnson JA, Bacon SL, et al. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med. 2013 Sep;20(3):385–96. DOI: 10.1007/s12529-012-9241-6. PMID: 22618308.
- Naliboff BD, Smith SR, Serpa JG, Laird KT, Stains J, Connolly LS, et al. Mindfulness-based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness. Neurogastroenterol Motil. 2020 Sep;32(9):e13828. DOI: 10.1111/nmo.13828. PMID: 32266762.
- Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014 Sep;109(9):1350–65; quiz 1366. DOI: 10.1038/ajg.2014.148. PMID: 24935275.
- Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH. Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial. Gastroenterology. 2021 Jun;160(7):2605-2607.e3. DOI: 10.1053/j.gastro.2021.02.058. PMID: 33662389. PMCID: PMC8202328.
- Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2019 Jan;4(1):20–31. DOI: 10.1016/S2468-1253(18)30310-8. PMID: 30473202.
- Hosseini-Asl MK, Taherifard E, Mousavi MR. The effect of a short-term physical activity after meals on gastrointestinal symptoms in individuals with functional abdominal bloating: a randomized clinical trial. Gastroenterol Hepatol Bed Bench. 2021;14(1):59–66. PMID: 33868611. PMCID: PMC8035544.
- Schumann D, Anheyer D, Lauche R, Dobos G, Langhorst J, Cramer H. Effect of yoga in the therapy of irritable bowel syndrome: a systematic review. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1720–31. DOI: 10.1016/j.cgh.2016.04.026. PMID: 27112106.
- Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010 Feb;25(2):252–8. DOI: 10.1111/j.1440-1746.2009.06149.x. PMID: 20136989.
- Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017 Aug 26;9(9). DOI: 10.3390/nu9090940. PMID: 28846594. PMCID: PMC5622700.
- Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. PLoS ONE. 2017 Aug 14;12(8):e0182942. DOI: 10.1371/journal.pone.0182942. PMID: 28806407. PMCID: PMC5555627.
- Dumitrascu DL, Baban A, Bancila I, Barboi O, Bataga S, Chira A, et al. Romanian guidelines for nonpharmacological therapy of IBS. J Gastrointestin Liver Dis. 2021 Jun 18;30(2):291–306. DOI: 10.15403/jgld-3581. PMID: 33951120.
- Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012 May;107(5):657–66; quiz 667. DOI: 10.1038/ajg.2012.49. PMID: 22488077.
- Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016 Apr 21;22(15):4009–19. DOI: 10.3748/wjg.v22.i15.4009. PMID: 27099444. PMCID: PMC4823251.
- Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut microbiome: profound implications for diet and disease. Nutrients. 2019 Jul 16;11(7). DOI: 10.3390/nu11071613. PMID: 31315227. PMCID: PMC6682904.
- Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014 Oct;109(10):1547–61; quiz 1546, 1562. DOI: 10.1038/ajg.2014.202. PMID: 25070051.
- Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017 Jul;33(7):1191–7. DOI: 10.1080/03007995.2017.1292230. PMID: 28166427.
- Tiequn B, Guanqun C, Shuo Z. Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis. Intern Med. 2015;54(3):243–9. DOI: 10.2169/internalmedicine.54.2710. PMID: 25748731.
- McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 2008 May 7;14(17):2650–61. DOI: 10.3748/wjg.14.2650. PMID: 18461650. PMCID: PMC2709042.
- Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014;7(3):156–63. PMID: 25120896. PMCID: PMC4129566.
- Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018 Feb 8;9(3):236–51. DOI: 10.1080/19490976.2017.1412908. PMID: 29227175. PMCID: PMC6219592.
- Martoni CJ, Srivastava S, Leyer GJ. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. Nutrients. 2020 Jan 30;12(2). DOI: 10.3390/nu12020363. PMID: 32019158. PMCID: PMC7071206.
- Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019 Apr 1;109(4):1098–111. DOI: 10.1093/ajcn/nqy376. PMID: 30949662.
- Spagnuolo R, Cosco C, Mancina RM, Ruggiero G, Garieri P, Cosco V, et al. Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017 Jun;21(2 Suppl):102–7. PMID: 28724171.
- Ciacci C, Franceschi F, Purchiaroni F, Capone P, Buccelletti F, Iacomini P, et al. Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS. Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):637–43. PMID: 21796867.
- Di Nardo G, Oliva S, Ferrari F, Mallardo S, Barbara G, Cremon C, et al. Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial. BMC Gastroenterol. 2013 Sep 24;13:142. DOI: 10.1186/1471-230X-13-142. PMID: 24063420. PMCID: PMC3849317.
- Kanazawa M, Fukudo S. Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med. 2006;13(3):214–20. DOI: 10.1207/s15327558ijbm1303_4. PMID: 17078771.
- Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004 Jan;49(1):73–7. DOI: 10.1023/b:ddas.0000011605.43979.e1. PMID: 14992438.
- Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011 Jan 6;364(1):22–32. DOI: 10.1056/NEJMoa1004409. PMID: 21208106.
- Lembo A, Zakko SF, Ferreira NL, Ringel Y., Bortey E, Courtney K, et al. T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response. Gastroenterology. 2008 Apr;134(4):A-545. DOI: 10.1016/S0016-5085(08)62544-5.
- Rice AD, Patterson K, Reed ED, Wurn BF, Robles K, Klingenberg B, et al. Decreasing recurrent bowel obstructions, improving quality of life with physiotherapy: Controlled study. World J Gastroenterol. 2018 May 21;24(19):2108–19. DOI: 10.3748/wjg.v24.i19.2108. PMID: 29785079. PMCID: PMC5960816.